Global Oncology Drug Discovery Services Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Oncology Drug Discovery Services Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Identification Service
  • 1.3.3 Authentication Service
  • 1.3.4 Hit-to-lead and Lead Optimization Services
  • 1.3.5 Others
• 1.4 Market by Application
  • 1.4.1 Global Oncology Drug Discovery Services Market Share by Application: 2020 VS 2026
  • 1.4.2 Research Institutes
  • 1.4.3 Pharmaceutical Companies
  • 1.4.4 Biotechnology Companies
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Oncology Drug Discovery Services Market Perspective (2015-2026)
• 2.2 Oncology Drug Discovery Services Growth Trends by Regions
  • 2.2.1 Oncology Drug Discovery Services Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Oncology Drug Discovery Services Historic Market Share by Regions (2015-2020)
  • 2.2.3 Oncology Drug Discovery Services Forecasted Market Size by Regions (2021-2026)
• 2.3 Oncology Drug Discovery Services Industry Dynamic
  • 2.3.1 Oncology Drug Discovery Services Market Trends
  • 2.3.2 Oncology Drug Discovery Services Market Drivers
  • 2.3.3 Oncology Drug Discovery Services Market Challenges
  • 2.3.4 Oncology Drug Discovery Services Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Oncology Drug Discovery Services Players by Market Size
  • 3.1.1 Global Top Oncology Drug Discovery Services Players by Revenue (2015-2020)
  • 3.1.2 Global Oncology Drug Discovery Services Revenue Market Share by Players (2015-2020)
• 3.2 Global Oncology Drug Discovery Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Oncology Drug Discovery Services Revenue
• 3.4 Global Oncology Drug Discovery Services Market Concentration Ratio
  • 3.4.1 Global Oncology Drug Discovery Services Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Oncology Drug Discovery Services Revenue in 2019
• 3.5 Key Players Oncology Drug Discovery Services Area Served
• 3.6 Key Players Oncology Drug Discovery Services Product Solution and Service
• 3.7 Date of Enter into Oncology Drug Discovery Services Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Drug Discovery Services Breakdown Data by Type

• 4.1 Global Oncology Drug Discovery Services Historic Market Size by Type (2015-2020)
• 4.2 Global Oncology Drug Discovery Services Forecasted Market Size by Type (2021-2026)

5 Oncology Drug Discovery Services Breakdown Data by Application

• 5.1 Global Oncology Drug Discovery Services Historic Market Size by Application (2015-2020)
• 5.2 Global Oncology Drug Discovery Services Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Oncology Drug Discovery Services Market Size (2015-2026)
• 6.2 North America Oncology Drug Discovery Services Market Size by Type (2015-2020)
• 6.3 North America Oncology Drug Discovery Services Market Size by Application (2015-2020)
• 6.4 North America Oncology Drug Discovery Services Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Oncology Drug Discovery Services Market Size (2015-2026)
• 7.2 Europe Oncology Drug Discovery Services Market Size by Type (2015-2020)
• 7.3 Europe Oncology Drug Discovery Services Market Size by Application (2015-2020)
• 7.4 Europe Oncology Drug Discovery Services Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Oncology Drug Discovery Services Market Size (2015-2026)
• 8.2 Asia-Pacific Oncology Drug Discovery Services Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Oncology Drug Discovery Services Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Oncology Drug Discovery Services Market Size (2015-2026)
• 9.2 Latin America Oncology Drug Discovery Services Market Size by Type (2015-2020)
• 9.3 Latin America Oncology Drug Discovery Services Market Size by Application (2015-2020)
• 9.4 Latin America Oncology Drug Discovery Services Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Oncology Drug Discovery Services Market Size (2015-2026)
• 10.2 Middle East & Africa Oncology Drug Discovery Services Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Oncology Drug Discovery Services Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 Charles River
  • 11.1.1 Charles River Company Details
  • 11.1.2 Charles River Business Overview
  • 11.1.3 Charles River Oncology Drug Discovery Services Introduction
  • 11.1.4 Charles River Revenue in Oncology Drug Discovery Services Business (2015-2020))
  • 11.1.5 Charles River Recent Development
• 11.2 Evotec
  • 11.2.1 Evotec Company Details
  • 11.2.2 Evotec Business Overview
  • 11.2.3 Evotec Oncology Drug Discovery Services Introduction
  • 11.2.4 Evotec Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 11.2.5 Evotec Recent Development
• 11.3 GE Healthcare Life Sciences
  • 11.3.1 GE Healthcare Life Sciences Company Details
  • 11.3.2 GE Healthcare Life Sciences Business Overview
  • 11.3.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Introduction
  • 11.3.4 GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 11.3.5 GE Healthcare Life Sciences Recent Development
• 11.4 GenScript
  • 11.4.1 GenScript Company Details
  • 11.4.2 GenScript Business Overview
  • 11.4.3 GenScript Oncology Drug Discovery Services Introduction
  • 11.4.4 GenScript Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 11.4.5 GenScript Recent Development
• 11.5 Horizon Discovery
  • 11.5.1 Horizon Discovery Company Details
  • 11.5.2 Horizon Discovery Business Overview
  • 11.5.3 Horizon Discovery Oncology Drug Discovery Services Introduction
  • 11.5.4 Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 11.5.5 Horizon Discovery Recent Development
• 11.6 TCG Lifesciences
  • 11.6.1 TCG Lifesciences Company Details
  • 11.6.2 TCG Lifesciences Business Overview
  • 11.6.3 TCG Lifesciences Oncology Drug Discovery Services Introduction
  • 11.6.4 TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 11.6.5 TCG Lifesciences Recent Development
• 11.7 Zumutor
  • 11.7.1 Zumutor Company Details
  • 11.7.2 Zumutor Business Overview
  • 11.7.3 Zumutor Oncology Drug Discovery Services Introduction
  • 11.7.4 Zumutor Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 11.7.5 Zumutor Recent Development
• 11.8 ChemPartner
  • 11.8.1 ChemPartner Company Details
  • 11.8.2 ChemPartner Business Overview
  • 11.8.3 ChemPartner Oncology Drug Discovery Services Introduction
  • 11.8.4 ChemPartner Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 11.8.5 ChemPartner Recent Development
• 11.9 Aquila BioMedical
  • 11.9.1 Aquila BioMedical Company Details
  • 11.9.2 Aquila BioMedical Business Overview
  • 11.9.3 Aquila BioMedical Oncology Drug Discovery Services Introduction
  • 11.9.4 Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 11.9.5 Aquila BioMedical Recent Development
• 11.10 Onconova
  • 11.10.1 Onconova Company Details
  • 11.10.2 Onconova Business Overview
  • 11.10.3 Onconova Oncology Drug Discovery Services Introduction
  • 11.10.4 Onconova Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 11.10.5 Onconova Recent Development
• 11.11 Vichem Chemie
  • 10.11.1 Vichem Chemie Company Details
  • 10.11.2 Vichem Chemie Business Overview
  • 10.11.3 Vichem Chemie Oncology Drug Discovery Services Introduction
  • 10.11.4 Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 10.11.5 Vichem Chemie Recent Development
• 11.12 GVK Biosciences
  • 10.12.1 GVK Biosciences Company Details
  • 10.12.2 GVK Biosciences Business Overview
  • 10.12.3 GVK Biosciences Oncology Drug Discovery Services Introduction
  • 10.12.4 GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 10.12.5 GVK Biosciences Recent Development
• 11.13 NuChem Therapeutics
  • 10.13.1 NuChem Therapeutics Company Details
  • 10.13.2 NuChem Therapeutics Business Overview
  • 10.13.3 NuChem Therapeutics Oncology Drug Discovery Services Introduction
  • 10.13.4 NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 10.13.5 NuChem Therapeutics Recent Development
• 11.14 Syncom
  • 10.14.1 Syncom Company Details
  • 10.14.2 Syncom Business Overview
  • 10.14.3 Syncom Oncology Drug Discovery Services Introduction
  • 10.14.4 Syncom Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 10.14.5 Syncom Recent Development
• 11.15 Envigo
  • 10.15.1 Envigo Company Details
  • 10.15.2 Envigo Business Overview
  • 10.15.3 Envigo Oncology Drug Discovery Services Introduction
  • 10.15.4 Envigo Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 10.15.5 Envigo Recent Development
• 11.16 DiverChim
  • 10.16.1 DiverChim Company Details
  • 10.16.2 DiverChim Business Overview
  • 10.16.3 DiverChim Oncology Drug Discovery Services Introduction
  • 10.16.4 DiverChim Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 10.16.5 DiverChim Recent Development
• 11.17 Aurora
  • 10.17.1 Aurora Company Details
  • 10.17.2 Aurora Business Overview
  • 10.17.3 Aurora Oncology Drug Discovery Services Introduction
  • 10.17.4 Aurora Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 10.17.5 Aurora Recent Development
• 11.18 HD Biosciences
  • 10.18.1 HD Biosciences Company Details
  • 10.18.2 HD Biosciences Business Overview
  • 10.18.3 HD Biosciences Oncology Drug Discovery Services Introduction
  • 10.18.4 HD Biosciences Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 10.18.5 HD Biosciences Recent Development
• 11.19 WuXi AppTec
  • 10.19.1 WuXi AppTec Company Details
  • 10.19.2 WuXi AppTec Business Overview
  • 10.19.3 WuXi AppTec Oncology Drug Discovery Services Introduction
  • 10.19.4 WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2015-2020)
  • 10.19.5 WuXi AppTec Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer